1,5-anhydrofructose has been researched along with Ischemic Stroke in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kikuchi, K; Maruyama, I; Nakanishi, K; Otsuka, S; Sakakima, H; Setoyama, K; Takada, S; Tanaka, E | 1 |
1 other study(ies) available for 1,5-anhydrofructose and Ischemic Stroke
Article | Year |
---|---|
1,5-anhydro-D-fructose induces anti-aging effects on aging-associated brain diseases by increasing 5'-adenosine monophosphate-activated protein kinase activity via the peroxisome proliferator-activated receptor-γ co-activator-1α/brain-derived neurotrophic
Topics: Adenosine Monophosphate; Aging; AMP-Activated Protein Kinases; Animals; Brain-Derived Neurotrophic Factor; Ischemic Stroke; Mice; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Rats; Transcription Factors | 2023 |